Aclarion, Inc. has scheduled its 2024 Annual Meeting of Stockholders for December [***], 2024, at 9:30 a.m. Mountain Time in Broomfield, Colorado. Key agenda items include the election of seven directors, ratification of Haynie & Company as the independent auditor, and approval of several stock issuance proposals under Nasdaq Listing Rule 5635(d).The meeting will also address a proposed reverse stock split, allowing the board to consolidate shares at a ratio between 1-for-5 and 1-for-400, aimed at maintaining Nasdaq listing compliance. Additionally, an amendment to the 2022 Equity Incentive Plan is proposed to increase the share reserve and annual grant limits.Stockholders of record as of November [***], 2024, are entitled to vote. The board recommends voting "FOR" all proposals. More details are available in the proxy statement on Aclarion's website.

Aclarion, Inc. has scheduled its 2024 Annual Meeting of Stockholders for December [***], 2024, at 9:30 a.m. Mountain Time in Broomfield, Colorado. Key agenda items include the election of seven directors, ratification of Haynie & Company as the independent auditor, and approval of several stock issuance proposals under Nasdaq Listing Rule 5635(d).The meeting will also address a proposed reverse stock split, allowing the board to consolidate shares at a ratio between 1-for-5 and 1-for-400, aimed at maintaining Nasdaq listing compliance. Additionally, an amendment to the 2022 Equity Incentive Plan is proposed to increase the share reserve and annual grant limits.Stockholders of record as of November [***], 2024, are entitled to vote. The board recommends voting "FOR" all proposals. More details are available in the proxy statement on Aclarion's website.